Ascletis files IND in US for monkeypox treatment
The drug candidate, ASC10, is being tested both to treat monkeypox and COVID-19, with trials underway already in the US for the latter indication.
The drug candidate, ASC10, is being tested both to treat monkeypox and COVID-19, with trials underway already in the US for the latter indication.
Purdue University and the pharma company will create a scholarship program and renew their strategic research collaboration as part of the agreement.
The company officially unveils its pharmaceutical distribution center that is based in Jeffersonville, Ohio.